These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 14315227

  • 21. MONOAMINE OXIDASE INHIBITORS: A REVIEW.
    HASTINGS GE.
    J Kans Med Soc; 1963 Sep; 64():409-18. PubMed ID: 14047794
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [CLINICAL-CHEMICAL STUDIES ON THE REACTION OF SEROTONIN METABOLISM TO MONOAMINE OXIDASE INHIBITION].
    SCHMID E, STOERMER ID, HAAS H, TAUTZ NA, SCHOEN H.
    Arzneimittelforschung; 1964 Aug; 14():849-52. PubMed ID: 14344123
    [No Abstract] [Full Text] [Related]

  • 25. [ENZYMATIC ACTIVITY IN BLOOD IN THE COURSE OF TREATMENT WITH MONOAMINE OXIDASE INHIBITORS (NIALAMIDE) OF AGED SUBJECTS].
    NESPOLI M, ROBUSTELLIDELLACUNA G, TAMMARO AE, ACCETTURA N.
    G Gerontol; 1964 Sep; 12():1091-4. PubMed ID: 14258418
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effect of amantadine on serotonin metabolism in the rat brain].
    Shimada S, Kimura M, Inagaki C, Fujita Y, Tanaka C.
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):801-9. PubMed ID: 4797067
    [No Abstract] [Full Text] [Related]

  • 28. The effect of monoamine oxidase inhibitors on the level of 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    ROOS BE.
    Life Sci (1962); 1963 Jan; 1():1-4. PubMed ID: 13974699
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
    GOLDBERG LI.
    JAMA; 1964 Nov 02; 190():456-62. PubMed ID: 14197995
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings?
    Bartonícek VJ.
    Pharmacology; 1970 Nov 02; 4(2):80-90. PubMed ID: 5528371
    [No Abstract] [Full Text] [Related]

  • 35. [NEW CONCEPTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS].
    ATDJIAN M, MACKENZIE AH, SCHERBEL AL.
    Prensa Med Argent; 1963 Feb 08; 50():432-6. PubMed ID: 14064380
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Anomalous actions of monoamine oxidase inhibitors.
    PSCHEIDT GR.
    Ann N Y Acad Sci; 1963 Jul 08; 107():1057-67. PubMed ID: 13972407
    [No Abstract] [Full Text] [Related]

  • 39. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Jul 08; 25(1):65-83. PubMed ID: 4775865
    [No Abstract] [Full Text] [Related]

  • 40. Analgesic effect of some monoamine oxidase inhibitors.
    Jauhari AC, Bapat SK.
    Indian J Physiol Pharmacol; 1971 Jan 08; 15(1):21-6. PubMed ID: 5122772
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.